NCT00407173已完成1 期
An Open-Label, Single-Dose, Parallel Group Study to Evaluate the Effects of Age and Gender on the Pharmacokinetics, Safety, and Tolerability of HCV-796 Administered Orally to Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 48 人开始时间: 2006年11月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
- 主要终点
- To evaluate the pharmacokinetic (PK) profile of HCV-796 in healthy men and women of different ages.
研究概览
简要总结
This study is an open-label, single-dose, parallel group study to evaluate the effects of age and gender on the pharmacokinetics, safety, and tolerability of HCV-796 administered orally to healthy subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
Experimental
HCV-796 1000mg single dose
干预措施: HCV-796 (Drug)
结局指标
主要结局
To evaluate the pharmacokinetic (PK) profile of HCV-796 in healthy men and women of different ages.
时间窗: 7 days
次要结局
- To assess the safety and tolerability of a single oral dose of HCV-796 in healthy men and women of different ages.(15 days)
研究者
相似试验
已完成
1 期
Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy AdultsHealthy VolunteerNCT01634191Amgen36
已完成
1 期
Study to Assess Effects of Age, Weight, and Body Composition on the Pharmacokinetics of IV Diclofenac SodiumHealthyNCT00509743Javelin Pharmaceuticals89
撤回
不适用
Clinical Trial to Assess the Influence of Gestational Stage and Maternal Age on Arterial Stiffness of the MotherPregnancy Trimester, FirstPregnancy Trimester, SecondPregnancy Trimester, ThirdNCT00180219Technische Universität Dresden
招募中
不适用
Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G)Digestive System DiseaseNeoplasmsNCT05066139Centre Paul Strauss144
已完成
不适用
Heat Wrap Device Safety With Age and Body FatBack PainNCT01355653Pfizer45